In breast cancer, the induction of HO-1 and its catalyzed byproduct, CO, by CUR can attenuate heat shock protein (HSP) 90 activity and its client proteins Akt, CDK4, and cyclinD1 to further suppress the invasion and proliferation of cells [44]. The gene discussed is CDK4; the disease is breast cancer.